ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/19/2025
Back to search
Official data from USPTO
CONFOCHIMERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CONFOCHIMERA
ST13
US500000097157132Class
1, 42
Filing
97157132
Registration
7078417
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
03/20/2025
Trademark type
Word
Nice classes
1, 42
Filing date
12/06/2021
Registration date
06/13/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2023
Last transaction
03/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
32
Owner location
GENT, BE
Examiner
KON, ELISSA
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CONFO THERAPEUTICS NV
Confo Therapeutics N.V.
Representatives
Elizabeth A. Cominolli MARKERT & COMINOLLI PLLC
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Laboratory chemicals for scientific use; biochemicals for in vitro and in vivo scientific use; biochemical substancesantibodies for stabilization of proteinsall the aforementioned substances for scientific use and for use in laboratories; reagents for medical research; diagnostic preparations for scientific or research use; chemical reagents for use in genetic research; receptors and reagents for testing for G protein-coupled receptors (GPCRs); Chemical substances for use in the production of drugs; Biochemical and chemical substances and chemical reagents for measuring combined or divided natural and non-natural G protein-coupled receptors (GPCRs); Proteins for use in science; Chimeric proteins to measuretest and develop compounds and ligands binding to G protein-coupled receptors (GPCRs)
Class 42
Medical and pharmacological research services; Pharmaceutical drug development services; Laboratory research services relating to pharmaceuticals; Research and development of vaccines and medicines; Scientific research for medical purposes and the development of pharmaceutical preparations in the area of chimeric proteinsantibodies for stabilization of proteins and G protein-coupled receptors (GPCRs)
Publications
History of USPTO decisions and trademark events.
17 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/13/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/28/2023
PUBO
PUBLISHED FOR OPPOSITION
03/28/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/17/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/17/2023
ALIE
ASSIGNED TO LIE
02/16/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/14/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/14/2022
GNSL
LETTER OF SUSPENSION E-MAILED
09/14/2022
CNSL
SUSPENSION LETTER WRITTEN
09/14/2022
DOCK
ASSIGNED TO EXAMINER
09/14/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2021
NWAP
NEW APPLICATION ENTERED
12/09/2021
Continuous trademark protection
Get notified about every new filing that threatens CONFOCHIMERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.